Etiologic heterogeneity of hyperapobetalipoproteinemia (hyperapoB). Results from segregation analysis in families with premature coronary artery disease
- PMID: 9409249
- DOI: 10.1161/01.atv.17.11.2729
Etiologic heterogeneity of hyperapobetalipoproteinemia (hyperapoB). Results from segregation analysis in families with premature coronary artery disease
Abstract
Hyperapobetalipoproteinemia (hyperapoB) is a common familial lipoprotein disorder associated with premature coronary artery disease (CAD). HyperapoB is characterized by an increased number of small, dense LDL particles. Patients with hyperapoB may be normotriglyceridemic (normoTG) or hypertriglyceridemic (hyperTG). We tested the hypothesis that a major locus controls the hyperapoB phenotype by using data from 1035 participants in 145 families enriched for premature CAD. Segregation analysis was conducted, and results suggest etiologic heterogeneity in these families. Families (n = 55) with one or more hyperTG hyperapoB individuals strongly supported mendelian recessive inheritance of hyperapoB. Under this mendelian model, individuals with the high-risk genotype had a baseline risk of 0.78, but parental and spouse's hyperapoB phenotypes did influence the probability of displaying hyperapoB. Low-risk genotypes had virtually no risk of displaying hyperapoB. The other subgroup of families (n = 72), in which all hyperapoB individuals were normoTG, did not show any clear pattern of inheritance. Eighteen families did not have any hyperapoB individual. In the 55 families with hyperTG hyperapoB, diabetes was more prevalent in hyperapoB individuals (18.3% of hyperTG hyperapoB individuals, 9.6% of normoTG hyperapoB individuals) than in normal individuals (4.9%). Both hyperTG hyperapoB and normoTG hyperapoB phenotypes were significant predictors for blood pressure in the 55 families, but not in the total population. These associations further suggest a link between hyperapoB and the small, dense LDL syndromes. This study successfully demonstrated mendelian inheritance of the hyperapoB phenotype and also suggested etiologic heterogeneity of hyperapoB.
Similar articles
-
Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women (< or = 60 years) with coronary artery disease.Am J Cardiol. 1993 Mar 15;71(8):631-9. doi: 10.1016/0002-9149(93)91002-y. Am J Cardiol. 1993. PMID: 8447257
-
HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease.Clin Chem. 1988;34(8B):B71-7. Clin Chem. 1988. PMID: 3042202 Review.
-
Pediatric hyperlipoproteinemia: the phenotypic expression of hyperapobetalipoproteinemia in young probands and their parents.Prog Clin Biol Res. 1988;255:89-105. Prog Clin Biol Res. 1988. PMID: 3340649
-
Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.J Endocrinol Invest. 2007 Jul-Aug;30(7):551-7. doi: 10.1007/BF03346348. J Endocrinol Invest. 2007. PMID: 17848837
-
Further insights into the pathophysiology of hyperapobetalipoproteinemia: role of basic proteins I, II, III.Clin Chem. 1991 Mar;37(3):317-26. Clin Chem. 1991. PMID: 2004437 Review.
Cited by
-
Segregation analysis of apolipoprotein A1 levels in families of adolescents: a community-based study in Taiwan.BMC Genet. 2006 Jan 20;7:4. doi: 10.1186/1471-2156-7-4. BMC Genet. 2006. PMID: 16423305 Free PMC article.
-
The role of non-LDL:non-HDL particles in atherosclerosis.Curr Diab Rep. 2002 Jun;2(3):282-8. doi: 10.1007/s11892-002-0096-0. Curr Diab Rep. 2002. PMID: 12643186 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous